DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALDMS - FR0012202497 - Common Stock
1.425 EUR
+0.01 (+0.71%)
We assign a fundamental rating of 2 out of 10 to ALDMS. ALDMS was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALDMS have multiple concerns. ALDMS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- ALDMS had negative earnings in the past year.
- ALDMS had a positive operating cash flow in the past year.
- In the past 5 years ALDMS always reported negative net income.
- The reported operating cash flow has been mixed in the past 5 years: ALDMS reported negative operating cash flow in multiple years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -2.92%, ALDMS is doing worse than 65.08% of the companies in the same industry.
- The Return On Equity of ALDMS (-13.33%) is worse than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.92% | ||
| ROE | -13.33% | ||
| ROIC | N/A |
ROA(3y)-9.22%
ROA(5y)-9.28%
ROE(3y)-35.31%
ROE(5y)-31.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of ALDMS (39.79%) is worse than 79.37% of its industry peers.
- In the last couple of years the Gross Margin of ALDMS has grown nicely.
- ALDMS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.79%
2. Health
2.1 Basic Checks
- ALDMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- ALDMS has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for ALDMS has been increased compared to 5 years ago.
- ALDMS has a better debt/assets ratio than last year.
2.2 Solvency
- ALDMS has an Altman-Z score of 1.06. This is a bad value and indicates that ALDMS is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 1.06, ALDMS is not doing good in the industry: 68.25% of the companies in the same industry are doing better.
- The Debt to FCF ratio of ALDMS is 7.73, which is on the high side as it means it would take ALDMS, 7.73 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 7.73, ALDMS is in line with its industry, outperforming 46.03% of the companies in the same industry.
- A Debt/Equity ratio of 0.79 indicates that ALDMS is somewhat dependend on debt financing.
- ALDMS's Debt to Equity ratio of 0.79 is on the low side compared to the rest of the industry. ALDMS is outperformed by 76.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.79 | ||
| Debt/FCF | 7.73 | ||
| Altman-Z | 1.06 |
ROIC/WACCN/A
WACC7.41%
2.3 Liquidity
- ALDMS has a Current Ratio of 1.16. This is a normal value and indicates that ALDMS is financially healthy and should not expect problems in meeting its short term obligations.
- ALDMS has a worse Current ratio (1.16) than 68.25% of its industry peers.
- A Quick Ratio of 0.62 indicates that ALDMS may have some problems paying its short term obligations.
- The Quick ratio of ALDMS (0.62) is worse than 82.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 0.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 86.92% over the past year.
- The Revenue has been growing slightly by 5.79% in the past year.
- ALDMS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.24% yearly.
EPS 1Y (TTM)86.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.18%
Revenue 1Y (TTM)5.79%
Revenue growth 3Y7.62%
Revenue growth 5Y8.24%
Sales Q2Q%3.07%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- ALDMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.02% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.75%
Revenue Next 2Y13.01%
Revenue Next 3Y12.65%
Revenue Next 5Y13.02%
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALDMS. In the last year negative earnings were reported.
- Based on the Price/Forward Earnings ratio of 27.67, the valuation of ALDMS can be described as expensive.
- ALDMS's Price/Forward Earnings ratio is in line with the industry average.
- When comparing the Price/Forward Earnings ratio of ALDMS to the average of the S&P500 Index (25.96), we can say ALDMS is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.67 |
4.2 Price Multiples
- ALDMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALDMS is cheaper than 92.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.18 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- ALDMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DIAGNOSTIC MEDICAL SYSTEMS / ALDMS.PA FAQ
Can you provide the ChartMill fundamental rating for DIAGNOSTIC MEDICAL SYSTEMS?
ChartMill assigns a fundamental rating of 2 / 10 to ALDMS.PA.
Can you provide the valuation status for DIAGNOSTIC MEDICAL SYSTEMS?
ChartMill assigns a valuation rating of 2 / 10 to DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA). This can be considered as Overvalued.
What is the profitability of ALDMS stock?
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) has a profitability rating of 1 / 10.
How financially healthy is DIAGNOSTIC MEDICAL SYSTEMS?
The financial health rating of DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) is 2 / 10.